Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
USD 494.00
2 Weeks
Anti-CD20 Reference Antibody (obinutuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-CD20 Reference Antibody (rituximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-CD20 Reference Antibody (TRU-015)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Cynomolgus |
| Conjugation | Unconjugated |
Anti-CD20 Reference Antibody (ripertamab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-CD20 Reference Antibody (ocrelizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-CD20 Reference Antibody (ublituximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-CD20 Reference Antibody (ofatumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-CD20 Reference Antibody (zuberitamab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-CD20 Reference Antibody (veltuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-CD20 Reference Antibody (ocaratuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-CD20 Reference Antibody (divozilimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- CD20
Reactivities
- Human
Applications
- ELISA